A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease

Experimental Hematology

Volumn 33, Issue 2, 2005, Pages 251-257

  Takabayashi, Maki ^a   Kanamori, Heiwa ^b   Takasaki, Hirotaka ^a   Yamaji, Satoshi ^a   Koharazawa, Hideyuki ^a   Taguchi, Jun ^a   Tomita, Naoto ^b   Fujimaki, Katsumichi ^a   Fujisawa, Shin ^b   Maruta, Atsuo ^c   Ishigatsubo, Yoshiaki ^a,d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; BONE MARROW TRANSPLANTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LEUKEMIA; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19944430231     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.10.009     Document Type: Article

References (40)

1. G.W. Santos, P.J. Tutschka, and R. Brookmeyer Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide N Engl J Med 309 1983 1347 1353
2. E.D. Thomas, R.A. Clift, and A. Fefer Marrow transplantation for the treatment of chronic myelogenous leukemia Ann Intern Med 104 1986 155 163
3. F.R. Appelbaum, K.M. Sullivan, and C.D. Buckner Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation J Clin Oncol 5 1987 1340 1347
4. J.R. Wingard, S. Piantadosi, and G.B. Vogelsang Predictors of death from chronic graft-versus-host disease after bone marrow transplantation Blood 74 1989 1428 1435
5. S.J. Forman, and J.A. Zaia Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 83 1994 2392 2398
6. H.M. Shulman, and W. Hinterberger Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation Bone Marrow Transplant 10 1992 197 214
7. D.A. Vallera, C.C. Soderling, G.J. Carlson, and J.H. Kersey Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone Transplantation 31 1981 218 222
8. R.L. Powles, G.R. Morgenstern, and H.E. Kay Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia Lancet 1 1983 612 615
9. P.G. Beatty, R.A. Clift, and E.M. Mickelson Marrow transplantation from related donors other than HLA-identical siblings N Engl J Med 313 1985 765 771
10. J.H. Antin, and J.L. Ferrara Cytokine dysregulation and acute graft-versus-host disease Blood 80 1992 2964 2968
11. D.H. Fowler, K. Kurasawa, R. Smith, M.A. Eckhaus, and R.E. Gress Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice Blood 84 1994 3540 3549
12. W. Krenger, K.M. Snyder, J.C. Byon, G. Falzarano, and J.L. Ferrara Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease J Immunol 155 1995 585 593
13. V. Rus, A. Svetic, P. Nguyen, W.C. Gause, and C.S. Via Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells Immunology 155 1995 2396 2406
14. T. Teshima, R. Ordemann, and P. Reddy Acute graft-versus-host disease does not require alloantigen expression on host epithelium Nat Med 8 2002 575 581
15. P. Herve, M. Flesch, and P. Tiberghien Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease Blood 79 1992 3362 3368
16. A.W. Rowbottom, P.G. Riches, C. Downie, and J.R. Hobbs Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation Bone Marrow Transplant 12 1993 635 641
17. H. Schwaighofer, M. Herold, and T. Schwarz Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation Transplantation 58 1994 430 436
18. N. Imami, P.A. Brookes, and G. Lombardi Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease Transplantation 65 1998 979 988
19. M. Remberger, M. Jaksch, M. Uzunel, and J. Mattsson Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation Eur J Haematol 70 2003 384 391
20. P. Reddy, and J.L. Ferrara Role of interleukin-18 in acute graft-vs.-host disease J Lab Clin Med 14 2003 365 371
21. J.E. Visentainer, S.R. Lieber, and L.B. Persoli Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation Exp Hematol 31 2003 1044 1050
22. M. Croft, L. Carter, S.L. Swain, and R.W. Dutton Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles J Exp Med 180 1994 1715 1728
23. R.A. Seder, and G.G. Le Gros The functional role of CD8+ T-helper type 2 cells J Exp Med 181 1995 5 7
24. A.M. Mowat Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction Immunology 68 1989 18 23
25. F.P. Nestel, K.S. Price, T.A. Seemayer, and W.S. Lapp Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease Exp Med 175 1992 405 413
26. L. Pan, J. Delmonte Jr., C.K. Jalonen, and J.L. Ferrara Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease Blood 86 1995 4422 4429
27. W. Krenger, K.R. Cooke, and J.M. Crawford Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease Transplantation 62 1996 1278 1285
28. D. Zeng, S. Dejbakhsh-Jones, and S. Strober Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation Blood 90 1997 453 463
29. H. Glucksberg, R. Storb, and A. Fefer Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 18 1974 295 304
30. E. Hagiwara, F. Abbasi, G. Mor, Y. Ishigatsubo, and D.M. Klinman Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood Cytokine 7 1995 815 822
31. G.R. Hill, T. Teshima, and A. Gerbitz Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia J Clin Invest 104 1999 459 467
32. M.R. van den Brink, E. Moore, K.J. Horndasch, J.M. Crawford, G.F. Murphy, and S.J. Burakoff Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease Transplantation 70 2000 184 191
33. T. Iwasaki, T. Hamano, and K. Saheki Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells Cell Immunol 197 1999 30 38
34. D.H. Fowler, J. Foley, and J. Whit-Shan Hou Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease Clin Gastroenterol Hepatol 2 2004 237 245
35. D. Niederwieser, M. Herold, and W. Woloszczuk Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages Transplantation 50 1990 620 625
36. H. Takatsuka, Y. Takemoto, and S. Yamada Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome Bone Marrow Transplant 26 2000 419 426
37. S. Abhyankar, D.G. Gilliland, and J.L. Ferrara Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens Transplantation 56 1993 1518 1523
38. W.J. Murphy, L.A. Welniak, and D.D. Taub Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice J Clin Invest 102 1998 1742 1748
39. B. Nikolic, S. Lee, R.T. Bronson, M.J. Grusby, and M. Sykes Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets J Clin Invest 105 2000 1289 1298
40. A. Franzke, W. Piao, and J. Lauber G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases Blood 102 2003 734 739